ReviewDer Nervenarzt2022
[From the social pediatric center to the medical center for adults with disabilities-transition in adults with complex disabilities].
Review in Der Nervenarzt, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Specific characteristics of mental disorders in people with disorders of intellectual development-Consequences for psychiatric and psychotherapeutic care].Der Nervenarzt · 2026Review
- The use of Botulinum Toxin Type A in patients in out-of-hospital intensive care in Germany-results from a multidisciplinary online survey.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The successful medical treatment of patients with complex disabilities requires care by multidisciplinary teams in social paediatric centers (German: SPZ) and medical centers for adults with disabilities (German: MZEB). These complement general outpatient medical care, which would be overwhelmed without this support. The quality of this care is crucial for the participation of patients and the prognosis of the disease. At the age of 18, this system requires a transition from the SPZ to the MZEB, which has not yet been satisfactorily regulated. The task and structural prerequisites for this are described. An inadequate or absent transition entails the risk of additional worsening of the course of the disease.
Indexed as
Identifiers
35348813What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.